Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the Literature

被引：0
|
作者：
O. Abdel-Rahman
Z. A. Elsayed
机构：
[1] Ain Shams University,Clinical Oncology Department, Faculty of Medicine
来源：
Digestive Diseases and Sciences | 2013年 / 58卷
关键词：
Hepatocellular carcinoma; TACE; Sorafenib; Combined treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3389 / 3396
页数：7
相关论文
共 50 条
  • [41] Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis
    Zhang, Leida
    Hu, Peng
    Chen, Xi
    Bie, Ping
    PLOS ONE, 2014, 9 (06):
  • [42] Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma
    Barone, M
    Ettorre, GC
    Ladisa, R
    Schiavariello, M
    Santoro, C
    Francioso, G
    Vinciguerra, V
    Francavilla, A
    HEPATO-GASTROENTEROLOGY, 2003, 50 (49) : 183 - 187
  • [43] Efficacy and safety analysis of TACE plus Donafenib plus Toripalimab versus TACE plus Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study
    Lu, Haohao
    Liang, Bin
    Xia, Xiangwen
    Zheng, Chuansheng
    BMC CANCER, 2023, 23 (01)
  • [44] Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry
    Geschwind, Jean-Francois H.
    Gholam, Pierre M.
    Goldenberg, Alec
    Mantry, Parvez
    Martin, Robert C. G.
    Piperdi, Bilal
    Zigmont, Ellen
    Imperial, Joanne
    Babajanyan, Svetlana
    Foreman, Pamela K.
    Cohn, Allen
    LIVER CANCER, 2016, 5 (01) : 37 - 46
  • [45] TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study
    Yang, Biao
    Jie, Luo
    Yang, Ting
    Chen, Mingyang
    Gao, Yuemei
    Zhang, Tian
    Zhang, Yuzu
    Wu, Hao
    Liao, Zhengyin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
    Liu, Jun-Ning
    Li, Ji-Jiang
    Yan, Shu
    Zhang, Guang-Nian
    Yi, Peng-Sheng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [47] Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A meta-analysis and systematic review
    Che, X.
    Zhang, W.
    Yin, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S80 - S80
  • [48] Sorafenib in combination with trans-arterial chemoembolization for advanced hepatocellular carcinoma: a retrospective Study at three German Liver centers
    Goeller, M.
    Fischer, K.
    den Winkel, P. Op
    den Winkel, M. Op
    Schott, E.
    Welker, M.
    Zangos, S.
    Vogl, T.
    Bechstein, W.
    Zeuzem, S.
    Kolligs, F.
    Trojan, J.
    INTERNIST, 2013, 54 : 35 - 35
  • [49] Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
    Liu, Lei
    Chen, Hui
    Wang, Mengmeng
    Zhao, Yan
    Cai, Guohong
    Qi, Xingshun
    Han, Guohong
    PLOS ONE, 2014, 9 (03):
  • [50] A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma
    Ghanaati, Hossein
    Mohammadifard, Mahyar
    Mohammadifard, Mahtab
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (10) : 3553 - 3560
12345